Don't forget to register to attend to the NanoHybrid 13 meeting:

Nano-H is a nanotechnology focused company in nanomedicine. The company has developed AGuIX, a nanoparticle designed to increase the detection of tumor by MRI and to boost the efficacy of radiation therapy

AGuIX is a technology having the potential to redesign the whole field of radiation oncology in the next decade. By being a MRI contrast agent, and because of its intrinsic properties, AGuIX product is a diagnostic and therapeutic product all-in-one.

Cancer is one of the leading causes of death with more than 7 million of deaths every year. Radiation therapy is used during the treatment of more than 60 % of cancer patients. AGuIX may significantly modify the therapeutic management of patients by increasing selectively the efficacy of the radiation treatment in the tumor.